Journal of Neuroinflammation · 2025 · 14 citations · 52 references
Life SciencesImmunologyNeuroscienceImmunoregulationInflammationNeuroimmunologyAcute Ischemic StrokeCytokine BiologyInflammatory SignalingNeuroinflammationNeuroprotectionStrokeCerebral Ischemia NeuroprotectionInterleukin-6 InhibitionLong-term Functional ImpairmentLong-term Neurologic OutcomesProinflammatory MediatorsSoluble Cytokine ReceptorsStat3 SignalingStroke Neuroprotection
INTRODUCTION: Elevated circulating IL-6 levels are associated with poorer outcomes after stroke, and increased serum IL-6 levels are linked to a higher risk of stroke. IL-6 binds to soluble IL-6 receptors (sIL-6R) and subsequently to ubiquitously expressed gp130, initiating proinflammatory trans-signaling. This study tested the hypothesis that inhibiting IL-6 trans-signaling by administering soluble (s) gp130 improves long-term functional outcomes in young mice after stroke. METHODS: Recombinant mouse gp130Fc chimera (sgp130) was administered one hour after middle cerebral artery occlusion (MCAO) followed by twice-weekly administration for 2 weeks in mice (8-15 weeks old). Behavioral assessments were done on days 7 and 28 post-MCAO for chronic studies. Flow cytometry was performed on days 3 (blood) and 7 (spleen and brain) to assess IL-6, mIL-6R, and phosphorylated STAT3 expression. RESULTS: Improved long-term functional outcomes were observed in male, but not female mice. To investigate the differential response in females, ELISA analyses revealed that plasma IL-6 levels increased in both sexes after MCAO, with a more pronounced induction in females. Additionally, circulating sIL-6R levels were significantly higher in females compared to males (p < 0.05) at 24 h post-MCAO. Administering a higher dose of sgp130 (1 mg/kg) to females improved long-term functional outcomes, suggesting that a higher dose is needed to inhibit IL-6 trans-signaling in females effectively. Mechanistically, sgp130 treatment reduced phosphorylated STAT3 expression in brain F4/80 macrophages and increased the expression of mIL-6R on splenic immune cells at day 7 post-MCAO in both sexes. CONCLUSION: These findings demonstrate that inhibition of IL-6 trans-signaling with gp130Fc improves long-term functional outcomes in both male and female mice, albeit in a dose-dependent manner. This study provides novel insights into potential therapeutic strategies targeting IL-6 signaling pathways following stroke.
52
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Manfred Köpf, Heinz Baumann, Giulia Freer et al. · Nature · 1994 · 1.8K citations
Life Sciences, Immunology, Pathology +16
Assessing nest building in mice
Robert M. J. Deacon · Nature Protocols · 2006 · 1.1K citations
Sex-specific transcriptional signatures in human depression
Benoît Labonté, Olivia Engmann, Immanuel Purushothaman et al. · Nature Medicine · 2017 · 803 citations · Full text
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
Meng Zhang, Qian Liu, Hui Meng et al. · Signal Transduction and Targeted Therapy · 2024 · 599 citations · Full text